QOF indicators used to compile the overall CHD quality achievement score
| Clinical domain | Summary statistics in this study (median and interquartile range) | |
|---|---|---|
| CHD | ||
| CHD06 | The percentage of patients with CHD in whom the last blood pressure reading (measured in the previous 15 months) is ≤150/90 mm Hg | 90 (85–93) |
| CHD08 | The percentage of patients with CHD whose last measured total cholesterol level (measured in the previous 15 months) is ≤5 mmol/L | 82 (78–87) |
| CHD09 | The percentage of patients with CHD with a record in the previous 15 months that aspirin, an alternative antiplatelet therapy, or an anticoagulant is being taken (unless a contraindication or adverse effects are recorded) | 95 (93–97) |
| CHD10 | The percentage of patients with CHD who are currently being treated with a β-blocker (unless a contraindication or adverse effects are recorded) | 73 (66–81) |
| CHD11 | The percentage of patients with a history of myocardial infarction (diagnosed after 1 April 2003) who are currently being treated with an ACE inhibitor or angiotensin II antagonist | 92 (88–97) |
| Stroke and TIA | ||
| STROKE06 | The percentage of patients with TIA or stroke in whom the last blood pressure reading (measured in the previous 15 months) is ≤150/90 mm Hg | 88 (82–92) |
| STROKE08 | The percentage of patients with TIA or stroke whose last measured total cholesterol level (measured in the previous 15 months) is ≤5 mmol/L | 76 (70–83) |
| Hypertension | ||
| BP05 | The percentage of patients with hypertension in whom the last blood pressure reading (measured in the previous 9 months) is ≤150/90 mm Hg | 77 (73–83) |
| Diabetes mellitus | ||
| DM12 | The percentage of patients with diabetes in whom the last blood pressure reading is ≤145/85 mm Hg | 80 (74–85) |
| DM17 | The percentage of patients with diabetes whose last measured total cholesterol level (measured in the previous 15 months) is ≤5 mmol/L | 83 (77–87) |
| DM20 | The percentage of patients with diabetes in whom the last HbA1C is ≤7.5 (or equivalent test/reference range depending on laboratory) in the previous 15 months | 67 (61–73) |
| Smoking | ||
| SMOKE02 | The percentage of patients with any of any combination of the following condition: CHD, stroke or TIA, hypertension, diabetes, COPD or asthma, who smoke and whose notes contain a record that smoking cessation advice or referral to a specialist service, where available, has been offered within the previous 15 months | 94 (92–96) |
| Kiran CHD overall achievement score | Mean of the above 12 indicators | 83 (80–86) |
CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HbA1c, glycated haemoglobin; TIA, transient ischaemic attack.